---
title: Head and Neck Cancer Screening and Serum Repository
nct_id: NCT00592371
overall_status: COMPLETED
sponsor: University of Arkansas
study_type: OBSERVATIONAL
primary_condition: Head and Neck Squamous Cell Cancer
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT00592371.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT00592371"
ct_last_update_post_date: 2012-09-05
last_seen_at: "2026-05-12T07:21:36.985Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Head and Neck Cancer Screening and Serum Repository

**NCT ID:** [NCT00592371](https://clinicaltrials.gov/study/NCT00592371)

## Key Facts

- **Status:** COMPLETED
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 300
- **Lead Sponsor:** University of Arkansas
- **Conditions:** Head and Neck Squamous Cell Cancer
- **Start Date:** 2006-03
- **Completion Date:** 2012-09
- **CT.gov Last Update:** 2012-09-05

## Brief Summary

Head and Neck Squaumous Cell Cancer(HNSCC) is the 6th most common cancer in the United States and the 3rd most common worldwide. Risk factors include abuse to tobacco and alcohol. Survival is related to stage of HNSCC when treatment is sought. Most HNSCC patients present with advanced staged disease. This screening activity will educate patients with HNSCC rick factors and screen for pre malignant and/or early staged lesions.

## Detailed Description

Otolaryngology staff memebers and residents will perform head and neck examinations upon participants after the participant has completed their questionnaire and had the opportunity to partcipate in the research portion by having blood drawn. A suspicious head and neck examination will be considered abnormal, and further recommendations for follow-up will be made. Participants will be provided with a list of practicing head and neck surgeons within the state of Arkansas.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

Exclusion Criteria:

* Under the age of 18 years of age
```

## Locations (1)

- University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.university of arkansas for medical sciences|little rock|arkansas|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT00592371.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT00592371*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*